ID: ALA2414976

Max Phase: Preclinical

Molecular Formula: C14H12N2

Molecular Weight: 208.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2c3c([nH]c2c1)-c1[nH]ccc1CC3

Standard InChI:  InChI=1S/C14H12N2/c1-2-4-12-10(3-1)11-6-5-9-7-8-15-13(9)14(11)16-12/h1-4,7-8,15-16H,5-6H2

Standard InChI Key:  PZQQCZIHXXNAIX-UHFFFAOYSA-N

Associated Targets(Human)

MAPK10 Tchem Mitogen-activated protein kinase 10/Receptor-interacting serine/threonine-protein kinase 1 (33 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 208.26Molecular Weight (Monoisotopic): 208.1000AlogP: 3.26#Rotatable Bonds: 0
Polar Surface Area: 31.58Molecular Species: NEUTRALHBA: 0HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.20CX LogD: 3.20
Aromatic Rings: 3Heavy Atoms: 16QED Weighted: 0.57Np Likeness Score: 0.36

References

1. Wu Z, Li Y, Cai Y, Yuan J, Yuan C..  (2013)  A novel necroptosis inhibitor-necrostatin-21 and its SAR study.,  23  (17): [PMID:23886688] [10.1016/j.bmcl.2013.06.073]

Source